Isolation and Identification of Mycobacterium tuberculosis with Mixed Growth from Positive MGIT 960 Cultures by Re-Decontamination

Tuberculosis (TB) caused by Mycobacterium tuberculosis has been identified as a remerging infectious disease with public health importance globally. Exploitation of better diagnosis techniques for precise isolation of mycobacteria in clinical specimens is of great importance to improve the diagnosis as part of the global TB control efforts. Contamination of broth cultures of acid-fast bacilli (AFB) by bacterial species other than Mycobacterium species frequently occurs. Many of these contaminated cultures require re-decontamination and re-incubation before the appropriate tests can be performed for identification. This study aimed at the isolation/recovery of M. tuberculosis from contaminated MGIT tubes by making minor modification to the standard protocol and access whether the modification has any impact on recovery rate. Among all confirmed 451 mixed growth positive cultures, 89.57% were culture positive (positive for MTBC), 3.80% were culture negative, 4.65% were culture contaminated and 1.99% were found NTM.

[1]  S. Dorman,et al.  New diagnostic tests for tuberculosis: bench, bedside, and beyond. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  V. Thomsen,et al.  Rapid, automated, nonradiometric susceptibility testing of Mycobacterium tuberculosis complex to four first-line antituberculous drugs used in standard short-course chemotherapy. , 2004, Diagnostic microbiology and infectious disease.

[3]  A. Aseffa,et al.  Direct Colorimetric Assay for Rapid Detection of Rifampin-Resistant Mycobacterium tuberculosis , 2004, Journal of Clinical Microbiology.

[4]  Chulhun L. Chang,et al.  Reduction of Contamination of Mycobacterial Growth Indicator Tubes with a Modified Antimicrobial Combination , 2002, Journal of Clinical Microbiology.

[5]  M. Cormican,et al.  Comparison of BACTEC MGIT 960 and BACTEC 460 for culture of Mycobacteria. , 2000, Diagnostic microbiology and infectious disease.

[6]  M. Gismondo,et al.  Multicenter Evaluation of the Mycobacteria Growth Indicator Tube for Testing Susceptibility of Mycobacterium tuberculosis to First-Line Drugs , 1999, Journal of Clinical Microbiology.

[7]  G. Woods,et al.  Evaluation of mycobacteria growth indicator tubes for susceptibility testing of Mycobacterium tuberculosis to isoniazid and rifampin. , 1995, Diagnostic microbiology and infectious disease.

[8]  David Satcher,et al.  Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities, 1994. Centers for Disease Control and Prevention. , 1994, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[9]  J. T. Crawford,et al.  The resurgence of tuberculosis: is your laboratory ready? , 1993, Journal of clinical microbiology.